Genetic instability associated with BRCA1 deficiency [28,33,34] is believed to be responsible for therapeutic failures, but the role of breast cancer stem cells in tumor progression and drug resistance in this disease are not known. The gene discussed is BRCA1; the disease is neoplasm.